| 9th Biennial Nonclinical Biostatistics Conference |
|
| New Frontiers in Drug Discovery and Development |
|
|
|
| FOUR TRACKS |
|
TWO SHORT COURSES |
|
|
|
|
|
Chemistry, Manufacturing, and Controls
Discovery & Biomarkers
Safety & Pharmacology
Data Sciences and Emerging Tools
|
|
A Primer on Spatial Transcriptomics Analysis
Dr. Joon Sang Lee, Sanofi
Making Project Work Better with R
Max Kuhn, Posit
|
|
|
|
|
ABOUT NCB: The Nonclinical Biostatistics Conference grew out of the Nonclinical Biostatistics Leaders’ Forum as a venue for nonclinical statisticians to discuss new and interesting technical methods. It is the only US-based conference devoted fully to the important work of nonclinical statistics, with topic areas spanning early discovery and biomarkers; safety and pharmacology; chemistry, manufacturing, and controls; and data sciences and emerging tools. The conference is sponsored by the American Statistical Association – Biopharmaceutical Section and features speakers from industry, regulatory, and academia.